ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,287.60
0.00%
Dow Jones
41,938.45
-1.63%
Brent Oil
80.395
-0.27%
Bitcoin
93,466.28
-1.08%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Asiakastieto Group Plc (0R6B) Quote

Asiakastieto Group Plc

Asiakastieto Group Plc (0R6B)

LSE
26.35
0.00
(0.00%)
Closed January 13 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
26.35
Bid
25.70
Ask
27.00
Volume
0.00
0.00 Day's Range 0.00
26.35 52 Week Range 26.35
Market Cap
626.998M
Previous Close
26.35
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
354
Shares Outstanding
23,795,000
Dividend Yield
-
PE Ratio
35.70
Earnings Per Share (EPS)
0.74
Revenue
156.3M
Net Profit
17.56M

About Asiakastieto Group Plc

Sector
Business Services, Nec
Industry
Business Services, Nec
Website
www.enento.com
Headquarters
Helsinki, Fin
Founded
-
Asiakastieto Group Plc is listed in the Business Services sector of the London Stock Exchange with ticker 0R6B. The last closing price for Asiakastieto was 26.35 €. Over the last year, Asiakastieto shares have traded in a share price range of 26.35 € to 26.35 €.

Asiakastieto currently has 23,795,000 shares outstanding. The market capitalization of Asiakastieto is 627.00 € million. Asiakastieto has a price to earnings ratio (PE ratio) of 35.70.

Ask ADVFN Intelligence (AI)

0R6B Latest News

More News

Enento Group Plc: SHARE REPURCHASE 12.1.2024

Enento Group Plc: SHARE REPURCHASE 12.1.2024 Enento Group PlcANNOUNCEMENT 12.1.2024      Enento Group Plc: SHARE REPURCHASE 12.1.2024    In the Helsinki Stock Exchange     Trade...

January 12 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 11.1.2024

Enento Group Plc: SHARE REPURCHASE 11.1.2024 Enento Group PlcANNOUNCEMENT 11.1.2024      Enento Group Plc: SHARE REPURCHASE 11.1.2024    In the Helsinki Stock Exchange     Trade...

January 11 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 10.1.2024

Enento Group Plc: SHARE REPURCHASE 10.1.2024 Enento Group PlcANNOUNCEMENT 10.1.2024      Enento Group Plc: SHARE REPURCHASE 10.1.2024    In the Helsinki Stock Exchange     Trade...

January 10 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 9.1.2024

Enento Group Plc: SHARE REPURCHASE 9.1.2024 Enento Group PlcANNOUNCEMENT 9.1.2024      Enento Group Plc: SHARE REPURCHASE 9.1.2024    In the Helsinki Stock Exchange     Trade...

January 09 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 8.1.2024

Enento Group Plc: SHARE REPURCHASE 8.1.2024 Enento Group PlcANNOUNCEMENT 8.1.2024      Enento Group Plc: SHARE REPURCHASE 8.1.2024    In the Helsinki Stock Exchange     Trade...

January 08 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 5.1.2024

Enento Group Plc: SHARE REPURCHASE 5.1.2024 Enento Group PlcANNOUNCEMENT 5.1.2024      Enento Group Plc: SHARE REPURCHASE 5.1.2024    In the Helsinki Stock Exchange     Trade...

January 05 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 4.1.2024

Enento Group Plc: SHARE REPURCHASE 4.1.2024 Enento Group PlcANNOUNCEMENT 4.1.2024      Enento Group Plc: SHARE REPURCHASE 4.1.2024    In the Helsinki Stock Exchange     Trade...

January 04 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 3.1.2024

Enento Group Plc: SHARE REPURCHASE 3.1.2024 Enento Group PlcANNOUNCEMENT 3.1.2024      Enento Group Plc: SHARE REPURCHASE 3.1.2024    In the Helsinki Stock Exchange     Trade...

January 03 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 2.1.2024

Enento Group Plc: SHARE REPURCHASE 2.1.2024 Enento Group PlcANNOUNCEMENT 2.1.2024      Enento Group Plc: SHARE REPURCHASE 2.1.2024    In the Helsinki Stock Exchange     Trade...

January 02 2024
GlobeNewswire Inc.

Enento Group Plc: SHARE REPURCHASE 29.12.2023

Enento Group Plc: SHARE REPURCHASE 29.12.2023 Enento Group PlcANNOUNCEMENT 29.12.2023      Enento Group Plc: SHARE REPURCHASE 29.12.2023    In the Helsinki Stock Exchange     Trade...

December 29 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10026.3526.3526.3525926.35DE
40026.3526.3526.3535626.35DE
120026.3526.3526.3535426.35DE
260026.3526.3526.3526126.35DE
520026.3526.3526.3546026.35DE
1560026.3526.3526.3572226.35DE
2600026.3526.3526.3557426.35DE

0R6B - Frequently Asked Questions (FAQ)

What is the current Asiakastieto share price?
The current share price of Asiakastieto is 26.35 €
How many Asiakastieto shares are in issue?
Asiakastieto has 23,795,000 shares in issue
What is the market cap of Asiakastieto?
The market capitalisation of Asiakastieto is EUR 627M
What is the 1 year trading range for Asiakastieto share price?
Asiakastieto has traded in the range of 26.35 € to 26.35 € during the past year
What is the PE ratio of Asiakastieto?
The price to earnings ratio of Asiakastieto is 35.7
What is the cash to sales ratio of Asiakastieto?
The cash to sales ratio of Asiakastieto is 4.01
What is the reporting currency for Asiakastieto?
Asiakastieto reports financial results in EUR
What is the latest annual turnover for Asiakastieto?
The latest annual turnover of Asiakastieto is EUR 156.3M
What is the latest annual profit for Asiakastieto?
The latest annual profit of Asiakastieto is EUR 17.56M
What is the registered address of Asiakastieto?
The registered address for Asiakastieto is HERMANNIN RANTATIE 6, PO BOX 16, FI-00580, HELSINKI, 00580
What is the Asiakastieto website address?
The website address for Asiakastieto is www.enento.com
Which industry sector does Asiakastieto operate in?
Asiakastieto operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 66.00
(0.00%)
1.65k
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 66.00
(0.00%)
1.65k
0R0XTesla Inc
$ 388.20
(0.00%)
4.24k
0JOQJd.com Inc
$ 72.00
(0.00%)
3.03k
0HCIAlibaba Group Holding Ltd
$ 81.10
(0.00%)
2.3k
0R1OAmazon.com Inc
$ 217.50
(0.00%)
1.67k
0P4FFord Motor Co
$ 9.665
(0.00%)
1.67k

Discussion

View Full Feed
sunspotter sunspotter 6 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 16 minutes ago
Marc loved your ides
tinojax tinojax 18 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 20 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 36 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 36 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 37 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 38 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 45 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 48 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 54 minutes ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 54 minutes ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 58 minutes ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 59 minutes ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 1 hour ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 1 hour ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 1 hour ago
Oh noooooo.....
FNMA
StockItOut StockItOut 1 hour ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 2 hours ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL

Your Recent History

LSE
0R6B
Asiakastieto
USOTC
ZLSUF
Zalatoris II Acquisition (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads